58
M. Andrei, K. Undheim / Tetrahedron: Asymmetry 15 (2004) 53–63
Major epimer: Rf 0.30 (Found: C, 63.46; H, 9.24.
C15H26N2O3 requires C, 63.80; H, 9.28%); HRMS:
[Mþ+H] 283.2015; C15H26N2O3+H requires 283.2021;
mmax (film/cmÀ1) 3460, 2971, 2943, 2871, 1694, 1641,
1462, 1436, 1241, 1197; dH (CDCl3) 0.65 (3H, d, J 6.7,
CH(CH3)2), 1.07 (6H, 2d, CH(CH3)2 and CHOHCH3),
1.66–1.92 (4H, m, 2 · CH2), 2.00 (1H, d, J 9.2,
CHOHCH3), 2.30–2.47 (1H, m, CH(CH3)2), 3.65 and
3.67 (6H, 2s, 2 · OCH3), 3.69–3.78 (1H, m, CHOHCH3),
3.88 (1H, d, J 3.4, H-5), 4.87–4.99 (2H, m, CH@CH2),
5.69–5.83 (1H, m, CH@CH2); dC (CDCl3) 17.0 and 19.5
(CH(CH3)2), 17.5 (CHOHCH3), 28.8 (CH2), 30.5
(CH(CH3)2), 34.6 (CH2), 52.2 and 52.3 (2 · OCH3), 60.6
(C-5), 65.3 (C-2), 73.0 (CHOH), 114.2 (CH@CH2),
138.7 (CH@CH2), 162.7 and 163.7 (2 · C@N); m=z (CI–
CH4) 283 (Mþ+H, 72%), 265 (15), 251 (8), 239 (30), 238
(31), 237 (100), 223 (18), 211 (27), 197 (23), 195 (99), 169
(25), 153 (5).
2 · CH@CH2); dC (CDCl3) 17.4, 17.6, 19.5 and 19.6
(2 · CH(CH3)2), 23.5 and 23.7 (2 · CHOHCH3), 30.6
and
31.0
(2 · CH(CH3)2),
42.2
and
46.1
(2 · CH2CH@CH2), 47.6 and 47.8 (2 · CH2CHOH),
52.2, 52.3, 52.4 and 52.8 (4 · OCH3), 60.1 and 60.9
(2 · C-5), 61.6 (2 · C-2), 64.6 and 65.5 (2 · CHOH),
117.9 and 118.0 (2 · CH@CH2), 133.7 and 134.1
(2 · CH@CH2), 163.1, 163.3, 163.6 and 164.3 (4 · C@N);
m=z (EI) 282 (Mþ, 1%), 241 (21), 209 (7), 198 (13), 197
(100), 181 (52), 155 (14).
4.4. (20S,50R)-1-[2-(3-Butenyl)-5-isopropyl-3,6-dimeth-
oxy-2,5-dihydropyrazin-2-yl]propan-2-ol 2d
Compound 2d was prepared as above from (2S,5R)-2-
(3-butenyl)-2,5-dihydro-5-isopropyl-3,6-dimethoxypyr-
azine 1b (2.00 g, 8.40 mmol) in THF (30 mL), under
argon, n-BuLi (5.77 mL, 9.24 mmol, 1.6 M in hexane)
and a solution of propylene oxide (0.803 g, 0.97 mL,
13.86 mmol) in THF (15 mL). The reaction product was
subjected to flash chromatography on silica gel using
EtOAc/hexane 3:7; Rf 0.32. The product consisted of
two alcohol epimers, in an inseparable mixture, in the
ratio 1:1; yield 1.720 g (62%). The epimer mixture was
used in the subsequent reaction. HRMS (electrospray):
[Mþ+H] 297.2180; C16H28N2O3+H requires 297.2172;
mmax (film/cmÀ1) 3383, 2969, 2944, 2871, 1694, 1654,
1642, 1460, 1437, 1381, 1230, 1198, 1144; dH (CDCl3)
0.64–0.69 (6H, 2d overlap, 2 · CH(CH3)2), 1.05–1.09
(9H, 3d overlap, 2 · CH(CH3)2 and CHOHCH3), 1.50–
2.08 (12H, m, 6 · CH2), 2.18–2.42 (2H, m,
2 · CH(CH3)2), 2.77 (1H, br s, OH), 3.63–3.71 (13H, 4s
and 1m, 4 · OCH3 and CHOHCH3), 3.89 (1H, d, J 3.4,
H-5), 3.95 (1H, d, J 3.4, H-5), 4.09–4.23 (1H, m,
CHOHCH3), 4.71 (1H, br s, OH), 4.87–4.94 (4H, m,
2 · CH@CH2), 5.69–5.80 (2H, m, 2 · CH@CH2); dC
(CDCl3) 17.1, 17.4 and 19.5, 19.6 (2 · CH(CH3)2), 23.6
and 23.6 (2 · CHOHCH3), 28.6 and 29.2 (2 · CH2), 30.5
and 30.9 (2 · CH(CH3)2), 36.5, 40.5, 48.3 and 48.4
(4 · CH2), 52.3 and 52.4 (4 · OCH3), 60.1 and 60.9
(2 · C-5), 60.3 (2 · C-2), 64.6 and 65.5 (2 · CHOH),
114.3 and 114.4 (2 · CH@CH2), 138.3 and 138.4
(2 · CH@CH2), 163.3, 163.6, 163.8 and 164.3 (4 · C@N);
m=z (CI–CH4) 297 (Mþ+H, 64%), 281 (8), 279 (6), 265
(17), 238 (8), 237 (56), 223 (11), 209 (7), 197 (13), 195
(100), 181 (16), 167 (6), 139 (7).
Minor epimer: Rf 0.22; dH (CDCl3) 0.65 and 1.05 (6H,
2d, J 6.8, CH(CH3)2), 0.85 (3H, d, J 6.2, CHOHCH3),
1.62–1.98 (4H, m, 2 · CH2), 2.26–2.37 (1H, m,
CH(CH3)2), 2.55 (1H, d, J 9.8, CHOHCH3), 3.61 and
3.65 (3H, 2s, 2 · OCH3), 3.79–3.87 (2H, m, CHOHCH3
and H-5), 4.84–4.95 (2H, m, CH@CH2), 5.67–5.78 (1H,
m, CH@CH2); dC (CDCl3) 17.2 and 19.5 (CH(CH3)2),
18.7 (CHOHCH3), 29.2 (CH2), 30.7 (CH(CH3)2), 35.6
(CH2), 52.1 and 52.5 (2 · OCH3), 60.8 (C-5), 64.9 (C-2),
72.3 (CHOH), 114.1 (CH@CH2), 138.5 (CH@CH2),
162.7 and 164.4 (2 · C@N).
4.3. (20S,50R)-1-(2-Allyl-5-isopropyl-3,6-dimethoxy-2,5-
dihydropyrazin-2-yl)propan-2-ol 2c
A solution of (2S,5R)-2-allyl-2,5-dihydro-5-isopropyl-
3,6-dimethoxypyrazine 1b (1.5 g, 6.7 mmol) in THF
(30 mL) under argon, was lithiated by the addition of
n-BuLi (4.60 mL, 7.37 mmol, 1.6 M in hexane) at )78 ꢁC,
the mixture stirred at this temperature for 30 min and a
solution of propylene oxide (0.70 mL, 0.583 g,
10.05 mmol) in THF (15 mL) added dropwise. The re-
sultant mixture was stirred at )78 ꢁC for 1 h, allowed to
reach ambient temperature and the reaction terminated
by addition of phosphate buffer pH 7 (25 mL). The
mixture was extracted with diethyl ether (3 · 20 mL),
the extracts dried (MgSO4) and the solvent evaporated.
The crude product was purified by flash chromatography
on silica gel using EtOAc/hexane 3:7. The product was a
colourless oil consisting of the two alcohol epimers 1:1;
Rf 0.22; yield 1.228 g (65%) (Found: C, 63.56; H, 9.12.
C15H26N2O3 requires C, 63.80; H, 9.28%); HRMS: M
282.1944; C15H26N2O3 requires 282.1943; mmax (film/
cmÀ1) 3406, 2944, 2872, 1694, 1462, 1437, 1237; dH
(CDCl3) 0.63 and 1.02 (6H, 2d, J 6.8, CH(CH3)2), 0.67
and 1.10 (6H, 2d, J 6.8, CH(CH3)2), 1.12 and 1.15 (6H,
4.5. (20R,50R)-1-(2-Allyl-5-isopropyl-3,6-dimethoxy-2,5-
dihydropyrazin-2-yl)ethanone 3a
A solution of (20S,50R)-1-(2-allyl-5-isopropyl-3,6-dimeth-
oxy-2,5-dihydropyrazin-2-yl)ethanol
2a
(0.850 g,
3.17 mmol) in dry dichloromethane (25 mL) was added
with stirring to a solution of the Dess–Martin reagent
(1.61 g, 3.8 mmol) in dry dichloromethane (20 mL) at
ambient temperature. The homogeneous reaction mix-
ture was diluted with diethyl ether (50 mL) after 1 h, and
the resulting suspension added to 1.3 M NaOH (30 mL).
The mixture was stirred for 10 min, the ether layer ex-
tracted with 1.3 M NaOH (25 mL) and water (25 mL).
The ether phase was dried (MgSO4), evaporated and
2d,
J
6.4, 2 · CHOHCH3), 1.55–2.07 (4H, m,
2 · CH2CHOH), 2.12–2.28 (2H, m, 2 · CH(CH3)2),
2.30–2.56 (4H, m, 2 · CH2CH@CH2), 2.90 (1H, br
s, CHOH), 3.60–3.64 (12H, 4s, 4 · OCH3), 3.79–3.95
(signals overlap, 3H, CHOHCH3 and 2 · H-5), 4.10–
4.25 (1H, m, CHOHCH3), 4.80 (1H, br s, CHOH), 4.92–
5.03 (4H, m, 2 · CH@CH2), 5.50–5.60 (2H, m,